Spotlight
Topic
Brand Insights
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Bright Beginnings: Pharm Exec Profiles Five Recent Drug Launches
Fllow the links below to read about each product:
Articles in this issue
ESG: Applying Lessons From Consumer Market
21st Annual Industry Audit: Pharma Performance Check
DE&I in Pharma Sales & Marketing: ‘While There’s Work, There’s Promise’
The Manufacturing Edge on Path to Market
How Good is a Good Product Launch?
Assessing HCP-Visit Fallout: COVID’s Ultimate Impact on New Drug Entrants
More Than a Name: Vyvgart
Fighting Vision Loss: Vabysmo
A Sleeping Giant?: Quviviq
Next-level Efficacy: Mounjaro
LDL Game Changer: Leqvio
Bright Beginnings: Pharm Exec Profiles Five Recent Drug Launches
Building a New Legacy
The Biotech Rally Continues—What’s Fueling the Surge?
Are Tighter Health System Policies for Sales Reps Looming?
Related Videos
Related Content
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Podcast
Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
